The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
2 weeks ago.....................
https://www.youtube.com/watch?v=vn6ZU6a4erY
Hia Andrew trust all good with you and happy new year m8ty...........
Pleased that you got you're top up, you we're always the largest shareholder here..........
Yep the twitter feed is good, would like to see a new video appertaining to customer sales, white label goods.......
Updated again today..................
https://twitter.com/apollon_uk
Eventually filled at 2.5p. Expecting to see a significant re-rate when licencing deal eventually lands.
Hi Kenny, just tried an order at 2.5p which hasn't been filled. Trying again at 2.6p.
We may finally see some movement...
Apollon using Twitter a lot at the moment and sounding upbeat.
GERMANY will become the largest country in the world to allow the sale of #cannabis with a net benefit to the state of €4.7bn a year, including €2.8bn in tax revenues and €1.36bn in savings on police and legal costs #drugspolicy https://ft.com/content/66016598-7307-4c07-a789-22d3973f2223
Apollon Formularies
@apollon_uk
·
1h
Apollon Formularies Jamaica is licensed to operate at the Federal level in Jamaica and holds the following licences:
??Human Research & Development
??Cannabis Cultivation
??Retail Dispensary
??Retail Therapeutic
??Processing
https://twitter.com/apollon_uk
LOL
Apollon Formularies
@apollon_uk
·
2h
Wishing everyone a Merry Christmas from the Apollon team ??
#Apollon
https://twitter.com/apollon_uk
maybe it was a false rise however will get there one day, gla all, merry christmas
:+)
Nice find Andrew REC......................
Like Big Tobacco companies, Big Pharma's interest in the medical cannabis industry grows with the space's fast-evolving cannabinoids industry. R&D on cannabinoids is achieving exciting results in the treatment application. For this reason, it is expected to see further involvement of pharmaceutical companies in the medical cannabis industry in the following years.
Another positive development in the medical cannabis market:
https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/
Only 68 views
https://www.youtube.com/watch?v=rg4jeqKtZs4
Apollon Formularies
@apollon_uk
·
12m
"We are excited that our formulations have been validated via independent laboratory testing to kill HER2+ breast cancer cells in 3D cell culture through direct cytotoxicity."
Stephen D. Barnhill, M.D., CEO of Apollon
Clinical data on CBD oil being recorded..................
Well....we have waited all this time, so what is a couple of years more.
I have actually added a few more today, but as usual it is showing as a sell because it is below the mid price.
Let's hope 2022 is the year when Apollon make significant inroads and agree a collaboration with at least one pharmaceutical company.
LOL
Apollon Formularies
@apollon_uk
·
41m
Apollon is developing a 3D printer to allow high quality medical cannabis pharmaceuticals with consistent dosing internationally with licensed partners
https://twitter.com/apollon_uk
Looking good, couple more years and someone will buy them out far better price than now but overall relatively cheap
Going to do very well this share one day, gla